Tagged with

doing business Insights from existing players on what to expect and how to succeed in Algeria today. “The key to being successful is to be direct and forthright with the Algerians themselves. Trust in them and they will certainly trust in you.” – Essam Farouk, CEO, El Kendi. “The pace of doing…

Oncology The following graph shows the comparitive spending on oncology products between 2010 and 2012 in the US, the EU, Japan, BRICs and other countries.

Since he took office in December 2012, President Enrique Peña Nieto has achieved much in terms of the number of major reforms passed in Mexico. Besides the most expected change opening the long-time state-run energy sector to foreign investment, Peña Nieto’s government undertook an ambitious program of reforms aimed at…

Parexel Pilar Rivas, associate director of global contract research organization Parexel’s Spanish affiliate, discusses cultural differences across Spain and their impact on clinical trials, as well as the world-class infrastructure that allows CROs in Spain to perform high-quality research.   Do you feel that supporting clinical research is a priority for the…

commercialization Founder of Promedon Marcelo Olmedo discusses innovation in Cordoba, and the birth and success of Promedon, a flagship company of the region.   How do you see the importance of the relationships between the private sector and the universities as being a key to success in the region?  In order…

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially life-threatening illness currently afflicting eight to ten million people worldwide. Latin America is home to the vast majority of Chagas patients, as the disease is most commonly transmitted through contact with the faeces of triatomine insects, also known…

sales UCB has transformed into a specialty care pharma which focuses on bringing solutions to patients suffering from severe chronic diseases. The vice president and region head for Americas discusses how the company re-entered key markets in the Latin American space to drive future growth, how the company’s three flagships products…

innovation Mexico is one of GSK’s growth engines in Latin America. The VP and general manager for Mexico discusses how the country is increasingly playing a strategic role for the company to get new healthcare products faster to the market by leveraging local R&D.     Besides Asia Pacific and Japan,…

Aspen Labs wants Latin America to be the third pillar of success for the company, and is doing it in a different way. The CEO for Spanish Latin America discusses the recent integration of the infant nutrition business from Nestlé (former Pfizer), the growth opportunities he sees and how he…

CNS Oh Pil-Soo, managing director of Lundbeck Korea, talks about the challenges of pricing and reimbursement in the CNS area and remaining committed to Korea in terms of clinical research.   What have been some of the biggest successes in the last three to four years for this affiliate? The greatest…

generics  Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth in the future.   You are currently the Vice President of CAPGEN; could you please tell us a bit about…

doing business The founder and president of Close Up International shares the story of the genesis, evolution, and growth of both his company and the prescription auditing industry, as well as his perspective on how the Argentinian pharmaceutical market differs from others in the region.   What opportunities did you see in…